Pathophysiology of preeclampsia;Physiopathologie de la prééclampsie

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 37, Issue 1, 2008, Pages 16-23

  Tsatsaris, V ^a,b,c,e   Fournier, T ^b,c,e   Winer, N ^d  

^a groupe hospitalier de Cochin ^*  (France)

^b INSERM   (France)

^c FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

^d NANTES UNIVERSITY HOSPITAL   (France)

^e PremUP   (France)

Author keywords

Angiogenesis; Placenta; Preeclampsia; Pregnancy; Trophoblast

Indexed keywords

CELL ADHESION MOLECULE; PROTEINASE;

ARTICLE; ENDOTHELIAL DYSFUNCTION; GENETIC PREDISPOSITION; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INFLAMMATORY DISEASE; OXYGEN TENSION; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PLACENTA DISORDER; PREECLAMPSIA; SCREENING TEST; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; UTERINE BLOOD VESSEL; VASCULARIZATION;

ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNITY; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; TROPHOBLASTS; UTERUS;

EID: 38549111998     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgyn.2007.08.003     Document Type: Article

References (69)

1. Meekins J.W., Pijnenborg R., Hanssens M., McFadyen I.R., and van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe preeclamptic pregnancies. Br J Obstet Gynaecol 101 (1994) 669-674
2. Redman C.W. Current topic: preeclampsia and the placenta. Placenta 12 (1991) 301-308
3. Multhaupt H.A., Mazar A., Cines D.B., Warhol M.J., and McCrae K.R. Expression of urokinase receptors by human trophoblast. A histochemical and ultrastructural analysis. Lab Invest 71 (1994) 392-400
4. Polette M., Nawrocki B., Pintiaux A., et al. Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Lab Invest 71 (1994) 838-846
5. Graham C.H., and McCrae K.R. Altered expression of gelatinase and surface-associated plasminogen activator activity by trophoblast cells isolated from placentas of preeclamptic patients. Am J Obstet Gynecol 175 (1996) 555-562
6. Pang Z.J., and Xing F.Q. Expression profile of trophoblast invasion-associated genes in the preeclamptic placenta. Br J Biomed Sci 60 (2003) 97-101
7. Genbacev O., Zhou Y., Ludlow J.W., and Fisher S.J. Regulation of human placental development by oxygen tension. Science 277 (1997) 1669-1672
8. Caniggia I., Grisaru-Gravnosky S., Kuliszewsky M., Post M., and Lye S.J. Inhibition of TGF-beta-3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 103 (1999) 1641-1650
9. Rajakumar A., Whitelock K.A., Weissfeld L.A., Daftary A.R., Markovic N., and Conrad K.P. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia. Biol Reprod 64 (2001) 499-506
10. Caniggia I., Mostachfi H., Winter J., et al. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta-3. J Clin Invest 105 (2000) 577-587
11. Zhou Y., Damsky C.H., Chiu K., Roberts J.M., and Fisher S.J. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 91 (1993) 950-960
12. Zhou Y., Damsky C.H., and Fisher S.J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?. J Clin Invest 99 (1997) 2152-2164
13. Kaufmann P., Black S., and Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intra-uterine growth retardation and preeclampsia. Biol Reprod 69 (2003) 1-7
14. Reister F., Frank H.G., Heyl W., et al. The distribution of macrophages in spiral arteries of the placental bed in preeclampsia differs from that in healthy patients. Placenta 20 (1999) 229-233
15. Reister F., Frank H.G., Kingdom J.C., et al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 81 (2001) 1143-1152
16. DiFederico E., Genbacev O., and Fisher S.J. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 155 (1999) 293-301
17. Huppertz B., Frank H.G., and Kaufmann P. Apoptosis along the invasive trophoblastic pathway. Placenta 19 (1998) A35
18. Lynch D.H., Ramsdell F., and Alderson M.R. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16 (1995) 569-574
19. Darmochwal-Kolarz D., Leszczynska-Gorzelak B., Rolinski J., and Oleszczuk J. The expression and concentrations of Fas/APO-1 (CD95) antigen in patients with severe preeclampsia. J Reprod Immunol 49 (2001) 153-164
20. Runic R., Lockwood C.J., Ma Y., Dipasquale B., and Guller S. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival. J Clin Endocrinol Metab 81 (1996) 3119-3122
21. Hsu C.D., Gutierrez L.S., Meaddough E., et al. Expression of FasL by preeclamptic placenta. Am J Obstet Gynecol 180 (1999) (1S-II) Supplement:p43S
22. Lim K.H., Zhou Y., Janatpour M., et al. Human cytotrophoblast differentiation/invasion is abnormal in preeclampsia. Am J Pathol 151 (1997) 1809-1818
23. Goldman-Wohl D.S., Ariel I., Greenfield C., et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with preeclampsia. Mol Hum Reprod 6 (2000) 88-95
24. Colbern G.T., Chiang M.H., and Main E.K. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta. Am J Obstet Gynecol 170 (1994) 1244-1250
25. Craven C.M., Morgan T., and Ward K. Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta 19 (1998) 241-252
26. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 (1997) 4-25
27. Carmeliet P., and Collen D. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr Top Microbiol Immunol 237 (1999) 133-158
28. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6 (2000) 389-395
29. Clark D.E., Smith S.K., Licence D., Evans A.L., and Charnock-Jones D.S. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF-C in the human placenta throughout gestation. J Endocrinol 159 (1998) 459-467
30. Zhou Y., Bellingard V., Feng K.T., McMaster M., and Fisher S.J. Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C. Dev Biol 263 (2003) 114-125
31. Pavlov N., Hatzi E., Bassaglia Y., Frendo J.L., Brion D.E., and Badet J. Angiogenin distribution in human-term placenta, and expression by cultured trophoblastic cells. Angiogenesis 6 (2003) 317-330
32. Zygmunt M., Hahn D., Munstedt K., Bischof P., and Lang U. Invasion of cytotrophoblastic JEG-3 cells is stimulated by HCG in vitro. Placenta 19 (1998) 587-593
33. Zygmunt M., Herr F., Keller-Schoenwetter S., et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 87 (2002) 5290-5296
34. Benirschke K., and Kaufmann P. Nonvillous parts and trophoblast invasion. Pathology of the human placenta (2000), Springer-Verlag, New York
35. Hubel C.A. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 222 (1999) 222-235
36. Walsh S.W., and Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 80 (1995) 1888-1893
37. Wang Y., Walsh S.W., and Kay H.H. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol 167 (1992) 946-949
38. Staff A.C., Halvorsen B., Ranheim T., and Henriksen T. Elevated level of free 8-iso-prostaglandin F-2-alpha in the decidua basalis of women with preeclampsia. Am J Obstet Gynecol 181 (1999) 1211-1215
39. Staff A.C., Ranheim T., Khoury J., and Henriksen T. Increased contents of phospholipids, cholesterol, and lipid peroxides in decidua basalis in women with preeclampsia. Am J Obstet Gynecol 180 (1999) 587-592
40. Davidge S.T. Oxidative stress and altered endothelial cell function in preeclampsia. Semin Reprod Endocrinol 16 (1998) 65-73
41. Davidge S.T., Hubel C.A., Brayden R.D., Capeless E.C., and McLaughlin M.K. Sera-antioxidant activity in uncomplicated and preeclamptic pregnancies. Obstet Gynecol 79 (1992) 897-901
42. Kharb S., Gulati N., Singh V., and Singh G.P. Lipid peroxidation and vitamin E levels in preeclampsia. Gynecol Obstet Invest 46 (1998) 238-240
43. Kharb S. Vitamin E and C in preeclampsia. Eur J Obstet Gynecol Reprod Biol 93 (2000) 37-39
44. Many A., Hubel C.A., Fisher S.J., Roberts J.M., and Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 156 (2000) 321-331
45. Hung T.H., Skepper J.N., Charnock-Jones D.S., and Burton G.J. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 90 (2002) 1274-1281
46. Huppertz B., Frank H.G., Kingdom J.C., Reister F., and Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol 110 (1998) 495-508
47. Redman C.W., and Sargent I.L. Placental debris, oxidative stress and preeclampsia. Placenta 21 (2000) 597-602
48. Redman C.W., and Sargent I.L. The pathogenesis of preeclampsia. Gynecol Obstet Fertil 29 (2001) 518-522
49. Huppertz B., Kingdom J., Caniggia I., et al. Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta 24 (2003) 181-190
50. Chua S., Wilkins T., Sargent I., and Redman C. Trophoblast deportation in preeclamptic pregnancy. Br J Obstet Gynaecol 98 (1991) 973-979
51. Smarason A.K., Sargent I.L., Starkey P.M., and Redman C.W. The effect of placental syncytiotrophoblast microvillous membranes from normal and preeclamptic women on the growth of endothelial cells in vitro. Br J Obstet Gynaecol 100 (1993) 943-949
52. Zhong X.Y., Laivuori H., Livingston J.C., et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 184 (2001) 414-419
53. Knight M., Redman C.W., Linton E.A., and Sargent I.L. Shedding of syncytiotrophoblast microvilli into the maternal circulation in preeclamptic pregnancies. Br J Obstet Gynaecol 105 (1998) 632-640
54. Cockell A.P., Learmont J.G., Smarason A.K., Redman C.W., Sargent I.L., and Poston L. Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function. Br J Obstet Gynaecol 104 (1997) 235-240
55. Dekker G.A., and Sibai B.M. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 179 (1998) 1359-1375
56. Conrad K.P., and Benyo D.F. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 37 (1997) 240-249
57. Levine R.J., Maynard S.E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
58. Venkatesha S., Toporsian M., Lam C., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12 (2006) 642-649
59. Hung T.H., Charnock-Jones D.S., Skepper J.N., and Burton G.J. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 164 (2004) 1049-1061
60. Hung T.H., Skepper J.N., and Burton G.J. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 159 (2001) 1031-1043
61. Roberts J.M. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 16 (1998) 5-15
62. Khalil R.A., and Granger J.P. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 283 (2002) R29-R45
63. Gaber L.W., Spargo B.H., and Lindheimer M.D. Renal pathology in preeclampsia. Baillieres Clin Obstet Gynaecol 8 (1994) 443-468
64. Eremina V., Sood M., Haigh J., et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111 (2003) 707-716
65. Maynard S.E., Min J.Y., Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
66. Luttun A., and Carmeliet P. Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered?. J Clin Invest 111 (2003) 600-602
67. Tsatsaris V., Goffin F., Munaut C., et al. Over expression of the soluble vascular endothelial growth factor receptor (sVEGFR-1) in preeclamptic patients: pathophysiological consequences. J Clin Endocr Metab (2003)
68. Gougos A., St Jacques S., Greaves A., et al. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 4 (1992) 83-92
69. Levine R.J., Lam C., Qian C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355 (2006) 992-1005